These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 28933054

  • 1. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.
    Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
    [Abstract] [Full Text] [Related]

  • 2. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S, Akhtar J, Wang Z.
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [Abstract] [Full Text] [Related]

  • 3. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
    Watanabe A, Suzuki H, Yokobori T, Tsukagoshi M, Altan B, Kubo N, Suzuki S, Araki K, Wada S, Kashiwabara K, Hosouchi Y, Kuwano H.
    Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
    [Abstract] [Full Text] [Related]

  • 4. Overcoming paclitaxel resistance in lung cancer cells via dual inhibition of stathmin and Bcl-2.
    Han ZX, Wang HM, Jiang G, Du XP, Gao XY, Pei DS.
    Cancer Biother Radiopharm; 2013 Jun; 28(5):398-405. PubMed ID: 23496232
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
    Ni PZ, He JZ, Wu ZY, Ji X, Chen LQ, Xu XE, Liao LD, Wu JY, Li EM, Xu LY.
    Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
    [Abstract] [Full Text] [Related]

  • 6. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Bai T, Yokobori T, Altan B, Ide M, Mochiki E, Yanai M, Kimura A, Kogure N, Yanoma T, Suzuki M, Bao P, Kaira K, Asao T, Katayama A, Handa T, Gombodorj N, Nishiyama M, Oyama T, Ogata K, Kuwano H.
    Br J Cancer; 2017 Apr 25; 116(9):1177-1185. PubMed ID: 28334732
    [Abstract] [Full Text] [Related]

  • 7. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
    Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K.
    Anticancer Res; 2018 Feb 25; 38(2):939-944. PubMed ID: 29374725
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
    Nie W, Xu MD, Gan L, Huang H, Xiu Q, Li B.
    Lab Invest; 2015 Jan 25; 95(1):56-64. PubMed ID: 25384122
    [Abstract] [Full Text] [Related]

  • 9. Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.
    Chen Y, Zhang Q, Ding C, Zhang X, Qiu X, Zhang Z.
    Int J Oncol; 2017 Jan 25; 50(1):31-40. PubMed ID: 27878293
    [Abstract] [Full Text] [Related]

  • 10. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
    Jiang W, Huang S, Song L, Wang Z.
    Oncol Rep; 2018 Feb 25; 39(2):834-842. PubMed ID: 29251330
    [Abstract] [Full Text] [Related]

  • 11. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A, Min IM, Crowley MJP, Panjwani SJ, Finnerty BM, Scognamiglio T, Liu YF, Whitsett TG, Garg S, Demeure MJ, Elemento O, Zarnegar R, Fahey TJ.
    Ann Surg Oncol; 2018 Mar 25; 25(3):792-800. PubMed ID: 29214451
    [Abstract] [Full Text] [Related]

  • 12. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
    Zhu HW, Jiang D, Xie ZY, Zhou MH, Sun DY, Zhao YG.
    Genet Mol Res; 2015 Dec 29; 14(4):18695-702. PubMed ID: 26782519
    [Abstract] [Full Text] [Related]

  • 13. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
    He X, Liao Y, Lu W, Xu G, Tong H, Ke J, Wan X.
    Tumour Biol; 2016 Jul 29; 37(7):9951-8. PubMed ID: 26815505
    [Abstract] [Full Text] [Related]

  • 14. STMN1 overexpression correlates with biological behavior in human cutaneous squamous cell carcinoma.
    Li X, Wang L, Li T, You B, Shan Y, Shi S, Qian L, Cao X.
    Pathol Res Pract; 2015 Nov 29; 211(11):816-23. PubMed ID: 26235036
    [Abstract] [Full Text] [Related]

  • 15. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
    Li J, Hu GH, Kong FJ, Wu KM, He B, Song K, Sun WJ.
    Neoplasma; 2014 Nov 29; 61(2):144-52. PubMed ID: 24299310
    [Abstract] [Full Text] [Related]

  • 16. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
    Bilguun EO, Kaira K, Kawabata-Iwakawa R, Rokudai S, Shimizu K, Yokobori T, Oyama T, Shirabe K, Nishiyama M.
    BMC Cancer; 2020 Sep 29; 20(1):935. PubMed ID: 32993587
    [Abstract] [Full Text] [Related]

  • 17. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
    Dos Santos Passaia B, Lima K, Kremer JL, da Conceição BB, de Paula Mariani BM, da Silva JCL, Zerbini MCN, Fragoso MCBV, Machado-Neto JA, Lotfi CFP.
    Invest New Drugs; 2020 Jun 29; 38(3):899-908. PubMed ID: 31441020
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL.
    Ann Surg Oncol; 2013 Nov 29; 20(12):4041-54. PubMed ID: 22911364
    [Abstract] [Full Text] [Related]

  • 20. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.
    J Thorac Oncol; 2013 Feb 29; 8(2):161-70. PubMed ID: 23287853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.